Targeted High Throughput Sequencing in the Diagnosis of Pediatric Acute Leukemia

Plain-language summary

This study investigates the diagnostic value of targeted high-throughput genetic sequencing in children with acute leukemia. It included patients aged 0-18 diagnosed with acute leukemia. It is a non-phase study and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Not Applicable

Status

Completed

Sponsor

Assistance Publique Hopitaux De Marseille

Intervention

blood draw

Start date

2/4/2014

Estimated completion

7/27/2023

Countries

France

Related genes

Locations

• Marseille, France

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* patients aged 0-18 years with a diagnosis of acute leukemia

Exclusion Criteria:

* patients without leukemia diagnosis
* patients for which the quantities obtained from DNA and RNA are insufficient